Pyridostigmine bromide 60 MG Oral Tablet [Mestinon] — RxCUI 903859
RxNorm drug concept · Semantic branded drug
RxCUI 903859
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI903859
Official namePyridostigmine bromide 60 MG Oral Tablet [Mestinon]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMestinon 60 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)910 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pyridostigmine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of it as a protective shield you put up before a threat arrives. Pyridostigmine temporarily occupies key spots on an enzyme in your body that soman would otherwise permanentl...
- What exactly is pyridostigmine supposed to do for me — does it actually stop soman from hurting me?
- Timing is everything with this medication. It needs to be started at least several hours before any anticipated exposure — not when an alarm goes off. If you take it immediately be...
- Does it matter when I take it? Can I just take it right before a threat?
🕸️ Concept Web — How Pyridostigmine bromide 60 MG Oral Tablet [Mestin... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pyridostigmine bromide 60 MG Oral Tablet [Mestinon]
RxCUI 903859 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Pyridostigmine
9000IN -
Pyridostigmine bromide
9001PIN
-
Pyridostigmine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mestinon
203001BN
-
Mestinon
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pyridostigmine Oral Tablet
373706SCDF -
Pyridostigmine bromide Oral Tablet
2647309SCDFP -
Pyridostigmine Oral Product
1163606SCDG -
Pyridostigmine Pill
1163607SCDG -
Pyridostigmine bromide Oral Product
2659335SCDGP -
Pyridostigmine bromide Pill
2661344SCDGP -
Pyridostigmine Oral Tablet [Mestinon]
369335SBDF -
Pyridostigmine bromide Oral Tablet [Mestinon]
2655903SBDFP - +5 more in this family
-
Pyridostigmine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pyridostigmine bromide 60 MG Oral Tablet
903857SCD -
Pyridostigmine bromide 60 MG
903856SCDC -
Pyridostigmine bromide 60 MG [Mestinon]
903858SBDC
-
Pyridostigmine bromide 60 MG Oral Tablet
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pyridostigmine bromide 60 MG Oral Tablet
SCD · 903857 -
Pyridostigmine bromide 60 MG
SCDC · 903856 -
Pyridostigmine Oral Tablet
SCDF · 373706 -
Pyridostigmine bromide Oral Tablet
SCDFP · 2647309 -
Pyridostigmine Oral Product
SCDG · 1163606 -
Pyridostigmine Pill
SCDG · 1163607 -
Pyridostigmine bromide Oral Product
SCDGP · 2659335 -
Pyridostigmine bromide Pill
SCDGP · 2661344
Brand-Name Concepts
-
Pyridostigmine bromide 60 MG [Mestinon]
SBDC · 903858 -
Pyridostigmine Oral Tablet [Mestinon]
SBDF · 369335 -
Pyridostigmine bromide Oral Tablet [Mestinon]
SBDFP · 2655903 -
Mestinon Oral Product
SBDG · 1185042 -
Mestinon Pill
SBDG · 1185043 -
Mestinon
BN · 203001
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 903859 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00187-3010-30 | 100 TABLET in 1 BOTTLE (0187-3010-30) | Mestinon | Bausch Health US, LLC | 1995-04-06 |
| 00187-3012-20 | 473 mL in 1 BOTTLE (0187-3012-20) | Mestinon | Bausch Health US, LLC | 1965-01-25 |
| 00187-3013-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30) | Mestinon | Bausch Health US, LLC | 1959-01-12 |
Observed labelers:
Bausch Health US, LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.